FR 2025-04768

The document from the Federal Register provides a notice regarding the revocation of Dr. Hazem Barmada's DEA registration. This registration allows a medical professional to handle controlled substances in the state of Mississippi. The Drug Enforcement Administration (DEA) decided to take this action because Dr. Barmada no longer has a valid medical license in Mississippi. This situation arose after he voluntarily surrendered his medical license to the Mississippi State Board of Medical Licensure in November 2021.

General Summary

Dr. Hazem Barmada, who was registered with the DEA in the state of Mississippi, had his registration revoked. This decision stems from the fact that he no longer holds a medical license in the state, a necessary condition for maintaining DEA registration to handle controlled substances. The revocation will not only cancel his current registration but also deny any pending applications related to this matter. The decision will be effective from April 21, 2025.

Significant Issues and Concerns

The document raises several important issues. Firstly, it highlights the critical requirement for medical professionals to maintain a valid state medical license to handle controlled substances legally. This requirement ensures that practitioners remain accountable to both state and federal regulations.

Another significant issue is the complexity and specificity of the language used in the document. It references particular sections of the U.S. Code and prior legal cases, making it potentially challenging for a layperson to understand without additional legal context or explanation.

Impact on the Public

This decision primarily serves the public's interest by ensuring that only licensed and qualified medical practitioners can handle controlled substances. This measure contributes to the broader effort to prevent misuse or illegal distribution of such substances, thereby protecting public health and safety.

Moreover, the decision underscores the importance for practitioners to adhere strictly to licensure requirements. Public trust in medical and regulatory systems hinges on strict compliance and enforcement of such rules, which can prevent medical malpractice or drug diversion.

Impact on Specific Stakeholders

For Dr. Barmada, this decision is undoubtedly detrimental. It removes his ability to legally handle prescribed controlled substances in Mississippi and could significantly impact his career and professional reputation. The revocation also underscores the importance of maintaining compliance with state medical regulations as a fundamental aspect of practicing medicine.

For other medical practitioners, this case serves as a critical reminder of the legal obligations surrounding medical licensure and DEA registration. It reinforces the necessity for compliance and might prompt careful attention to maintaining up-to-date licensure to prevent similar occurrences.

Lastly, the enforcement action by the DEA exemplifies the agency's commitment to uphold legal and medical standards. For regulatory and legal bodies, it highlights the ongoing responsibility to monitor practitioners and enforce necessary measures to ensure compliance with regulations that protect public health.